Biogend Therapeutics Co.ltd
Clinical trials sponsored by Biogend Therapeutics Co.ltd, explained in plain language.
-
New bone graft shows promise for mending tough leg breaks
Disease control CompletedThis study tested a new bone graft material (OIF/β-TCP) in 35 people with severe open fractures of the shin bone (tibia). The goal was to see if it helps bones heal when they are slow to mend. Participants were followed for up to 52 weeks after the graft was implanted.
Phase: NA • Sponsor: BioGend Therapeutics Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New scaffold implant shows promise for damaged knee cartilage
Disease control CompletedThis study tested a special implant called BiCRI in 11 people with knee cartilage damage. The implant is a scaffold that helps new cartilage grow. Researchers measured pain, knee function, and tissue healing. The goal was to see if the implant is safe and works for tough cases, i…
Phase: NA • Sponsor: BioGend Therapeutics Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC